Moderna (MRNA) Net Cash Flow (QoQ) (2018 - 2026)
Moderna (MRNA) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,899.87 Bn | 1,899.81 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 470.43 Bn | 465.64 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.43 Bn | 116.19 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.20 Bn | 61.44 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.75 Bn | 61.75 Bn | - |
| 8 | Argenx Se | 56.15 Bn | 50.96 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn |
| 10 | Moderna | 21.97 Bn | 16.77 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -147.10% |
| Dec 31, 2025 | 1,088.51% |
| Sep 30, 2025 | 57.23% |
| Jun 30, 2025 | -14.19% |
| Mar 31, 2025 | -207.07% |
| Dec 31, 2024 | 133.93% |
| Sep 30, 2024 | -303.91% |
| Jun 30, 2024 | 147.72% |
| Mar 31, 2024 | -3,328.00% |
| Dec 31, 2023 | 97.12% |
| Sep 30, 2023 | -340.72% |
| Jun 30, 2023 | 47.95% |
| Mar 31, 2023 | 38.64% |
| Dec 31, 2022 | 12.82% |
| Sep 30, 2022 | 107.17% |
| Jun 30, 2022 | -20.83% |
| Mar 31, 2022 | -238.57% |
| Dec 31, 2021 | 2,550.94% |
| Sep 30, 2021 | -132.92% |
| Jun 30, 2021 | -94.28% |